BioSpace News Archive

7 Passive-Aggressive Phrases to Avoid in Workplace Emails

Unlike face-to-face conversations or even phone calls where you can easily pick up on things like the other person’s tone, intent, and nuance, email communication is often more ambiguous… and problematic.

February 21, 2019

·

3 min read

·

Editorial Staff

Policy

J&J Hit With Federal Subpoenas Over Baby Powder Contamination Allegations

Johnson & Johnson’s iconic talcum powder product has been the subject of lawsuits and a scathing report that indicated the company allegedly knew that carcinogenic asbestos was sometimes found in the product. As a result, the company has received subpoenas from the federal government.

February 21, 2019

·

2 min read

·

Alex Keown

Business

Morphic and Janssen to Collaborate in Deal Worth up to $750 Million

Waltham, Mass.-based Morphic Therapeutic and Janssen Biotech, a division of Johnson & Johnson, entered into a collaborative deal to develop novel integrin therapeutics for patients with conditions not adequately addressed by current therapies.

February 21, 2019

·

2 min read

·

Alex Keown

Deals

Firmly on our way to becoming a fully integrated biopharma company

FINCH 2 Phase 3 trial with filgotinib in rheumatoid arthritis (RA) met all primary and secondary endpoints, with consistent tolerability

February 21, 2019

·

12 min read

Policy

High Dose of Pfizer’s Xeljanz Raises Red Flag in a Post-Marketing Study

Pfizer’s blockbuster rheumatoid arthritis drug Xeljanz, a JAK inhibitor, has been a strong performer for the company, bringing in $1.77 billion in revenue last year. But now the company has indicated it intends to make a change in its post-marketing study due to safety concerns.

February 21, 2019

·

2 min read

·

Alex Keown

Deals

Merck Acquires Immune Design for $300 Million in Cash

Shares of Immune Design are skyrocketing in premarket trading today after Merck announced it will acquire the Seattle-based oncology company for $300 million in cash. Immune Design stock has shot up more than 310 percent to $5.83 in early trading.

February 21, 2019

·

2 min read

·

Alex Keown

Policy

Meet the Pharma Reps About to Face the Senate Over Pricing Concerns

Seven pharma executives will enter the Congressional crucible next week as they face questions and concerns over the rising costs of prescription drugs.

February 21, 2019

·

3 min read

·

Alex Keown

Drug Development

Feb. 22 Research Roundup: Hearing Restoration, Depression, Marrow Transplants and Aging and MS

Research is the cornerstone of new medications that treat numerous needs across the globe. Here’s a look at a few of the interesting research stories that crossed BioSpace’s slice of the Internet.

February 21, 2019

·

3 min read

·

Alex Keown